Agoracom: Small Cap Investment - Zenith Epigenetics - Why have we not heard more about CURATE-AI?

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

narmac

Rank: Vice President [?]

Points: 3973 [?]

Votes: 36 Score: 3.0 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Why have we not heard more about CURATE-AI?

posted on Mar 24, 2021 06:55AM

Remember the blurb back a couple years when the Curate AI platform made a successful treatment for the gent with stage 4 prostate cancer!! Seems this stunning success died a slow death, have never heard any follow up around it!

https://onlinelibrary.wiley.com/doi/abs/10.1002/adtp.201800104

3 Recommendations

Re: Why have we not heard more about CURATE-AI?

KOO-KOO2

Mar 24, 2021 09:45AM

Re: Why have we not heard more about CURATE-AI?

KOO-KOO2

Mar 24, 2021 10:50AM

Re: Why have we not heard more about CURATE-AI?

Toinv

Mar 25, 2021 11:12AM

Re: Why have we not heard more about CURATE-AI?